Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Market Open

Julia Lee
December 21, 2016

Market Update

Julia Lee
December 19, 2016

Market Update

Julia Lee
December 16, 2016

Market Update

Julia Lee
December 15, 2016

Market update 14 December

Julia Lee
December 14, 2016

Market Update

Julia Lee
December 12, 2016

Market Update

Julia Lee
December 5, 2016

Market Update

Julia Lee
December 2, 2016

Market Update

Julia Lee
December 1, 2016

2016 Overview

Julia Lee
November 28, 2016

Market Update

Julia Lee
November 17, 2016

Peter Quinton on Trump’s victory

Bell Direct
November 17, 2016